By Victoria Stilwell
General Electric Co. (GE) will invest $7.5 million in Nanosonics Ltd. (NAN.AU) to help the Australian-based healthcare specialist further develop and distribute an ultrasound disinfecting system.
Nanosonics, which develops products used to control infections, created its Trophon EPR product to reduce infections spread between patients through ultrasound transducers. GE worked with the specialist in 2006 to support validation of the product, and it received FDA approval in 2011.
GE said the investment complements the company's portfolio of ultrasound technologies, services and software and will expand GE's sales footprint in Japan and other locations.
Nanosonics in May said it seeks to raise about $15.4 million in new capital through issuing new shares at a 6% premium.
Shares of GE were down 1% to $19.60 in premarket trade.
-Write to Victoria Stilwell at Victoria.Stilwell@dowjones.com
(END) Dow Jones Newswires
June 25, 2012 07:34 ET (11:34 GMT)
Copyright (c) 2012 Dow Jones & Company, Inc.